Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington’s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalDefault journal
StatePublished - 2007

Fingerprint

Dive into the research topics of 'Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington’s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.'. Together they form a unique fingerprint.

Cite this